Naomi Cooper
Investment firms Veritas Capital and KKR have agreed to invest in Cotiviti, a provider of data analytics services to health care organizations, to support the latter’s commercial expansion and product development efforts.
Veritas Capital and KKR will own equal ownership stakes in Cotiviti and allocate capital through their venture capital funds to help accelerate the company’s fund growth and technology innovation investments, Cotiviti said Wednesday.
Under the recapitalization agreement, Cotiviti will secure funding from the KKR North America Fund XIII and the Veritas Fund VIII.
“Over the course of our investment, Veritas partnered with Cotiviti to drive a period of sustained transformative growth both organically and through strategic acquisitions, building a mission critical suite of solutions that have helped to reshape the economics of healthcare,” said Ramzi Musallam, CEO and managing partner of Veritas and a 2024 Wash100 awardee.
Musallam said Veritas and KKR are confident that Cotiviti will “play an increasingly vital role” in enhancing the health care sector through proprietary data, technology and analytics.
